Syngene International Employee Stock Options

Syngene International Earnings Call Transcript: Key Takeaways

Syngene reports a transitional quarter with sequential recovery but YoY declines due to the absence of the large Librela revenue stream.

Syngene International Investor Presentation: Key Takeaways

Q2 FY27 revenue Rs 833 Cr (down 9% YoY, up 13% QoQ). Operating EBITDA margin 18% on forex hedge losses. PAT before exceptionals Rs 38 Cr (down 44% YoY). Focus on integrated CRDMO and first Bayview biologics deal.

Syngene International Results Update

Syngene reported Q2 FY27 revenue of Rs 833 Crore, up 13% sequentially, with PAT of Rs 32 Crore. Release includes P&L highlights and business updates.

Syngene International Management Change

Syngene reports changes in senior management: two heads move from SMP to Non-SMP, Ajay Tandon resigns effective October 30, 2026, and CFO Deepak Jain plans to leave. The CFO is a KMP, so this is a material leadership change.

Syngene International Q2 FY27 Results: Net Profit ₹32.2 Cr, Down 52.0% YoY

Syngene International Ltd reported revenue from operations of ₹832.7 Cr (-8.6% YoY) and net profit of ₹32.2 Cr (-52.0% YoY) for Q2 FY27.

Key figure

Net profit ₹32.2 Cr · -52.0% YoY

Syngene International Other Announcement

Syngene International Limited has submitted the quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.

Shaily Engineering Plastics Employee Stock Options

Shaily Engineering Plastics allotted 1,300 equity shares to employees on exercise of ESOPs at Rs. 732 per share under its 2019 plan. Issued paid-up capital rises to 4,59,96,548 shares of Rs. 2 each.

Info Edge (India) Employee Stock Options

Info Edge's employee stock option trust sold 1,439 shares on 26 October 2026 under the ESOP scheme. The disposal reduces the trust's holding to 410,707 shares.

Motilal Oswal Financial Services Employee Stock Options

Motilal Oswal Financial Services granted 2,20,000 stock options to eligible employees under its ESOP Scheme X. No exercise price or monetary value is disclosed.

Borosil Employee Stock Options

Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.

Execution

Vesting over 3 years from grant date

Natco Pharma Employee Stock Options

Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.

Value

₹144.2 Cr

Coforge Employee Stock Options

Coforge allotted 24,242 equity shares under its ESOP (2005) scheme on 29 October 2026. Paid-up capital rises to 44,30,62,864 equity shares.